Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06625385 · ClinicalTrials.gov registry record · NA

A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing

A NA study of Wound, sponsored by Solventum US.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
3
Study locations

NCT06625385 is a NA study of Wound that is actively recruiting participants, run by Solventum US. The registered enrollment target is 90 participants, below the 414-participant average among 8 other Wound trials with a reported enrollment target (78% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06625385, a NA study of Wound, is actively recruiting participants, sponsored by Solventum US.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this clinical study is to obtain post-market safety and efficacy data when the V.A.C.® Peel and Place dressing is used in conjunction with 3M™ V.A.C.® Therapy.

Conditions Studied

Wound

Interventions

  • DEVICE 3M™ V.A.C.® Peel and Place Dressing

Study Locations (3)

Indiana

  • IU Health Methodist Hospital - Indianapolis

Missouri

  • Washington University - Barnes Jewish Hospital - St Louis

Pennsylvania

  • St. Luke's University Hospital - Bethlehem

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-01-20
Est. Completion 2027-05
Phase NA

Sponsor

Solventum US

41 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06625385

The ClinicalTrials.gov registry entry for NCT06625385 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 414-participant average among 8 other Wound trials with a reported enrollment target (78% lower). The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Wound appearing as the primary indexed condition, and to 1 intervention - of which 3M™ V.A.C.® Peel and Place Dressing is the first listed.

NCT06625385 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Indiana, Missouri, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06625385 about?

NCT06625385 is a clinical study titled "A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing". The purpose of this clinical study is to obtain post-market safety and efficacy data when the V.A.C.® Peel and Place dressing is used in conjunction with 3M™ V.A.C.® Therapy.

What is the current status of trial NCT06625385?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-01-20. Estimated completion is 2027-05.

What conditions does trial NCT06625385 study?

This clinical trial studies the following conditions: Wound.

What interventions are being tested in trial NCT06625385?

The interventions under investigation include: 3M™ V.A.C.® Peel and Place Dressing (DEVICE).

Who is sponsoring clinical trial NCT06625385?

This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06625385 being conducted?

This trial has 3 study locations across Indiana, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Wound

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Wound

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.